Bromma, Sweden

Lisbet Nilvebrant

This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia Aktiebolag. Active years: 1995.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lisbet Nilvebrant: Innovator in Pharmaceutical Chemistry

Introduction

Lisbet Nilvebrant is a notable inventor based in Bromma, Sweden. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. Her work has led to the creation of innovative drugs that address various medical needs.

Latest Patents

Lisbet holds a patent for her invention titled "3,3-diphenylpropylamines and pharmaceutical compositions thereof." This patent describes novel 3,3-diphenylpropylamines characterized by specific chemical structures. The compounds are designed to function as anticholinergic agents, with potential applications in drug formulation and therapeutic treatments.

Career Highlights

Throughout her career, Lisbet has been associated with Pharmacia Aktiebolag, where she has contributed to various research initiatives. Her expertise in pharmaceutical chemistry has been instrumental in advancing the company's product offerings. She has a proven track record of innovation, with her patent reflecting her commitment to improving healthcare solutions.

Collaborations

Lisbet has collaborated with esteemed colleagues, including Nils A Jonsson and Bengt Ang Sparf. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.

Conclusion

Lisbet Nilvebrant's contributions to pharmaceutical chemistry exemplify her dedication to innovation and improving medical treatments. Her patent and collaborative efforts highlight her role as a significant figure in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…